Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma

Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma

Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common subtypes of renal cancer, with 30% of patients presenting with systemic disease at diagnosis. This aggressiveness is a consequence of the activation of epithelial–mesenchymal transition (EMT) caused by many different inducers...

Full description

Bibliographic Details
Main Authors: Martyna Parol‐Kulczyk, Justyna Durślewicz, Laura Blonkowska, Radosław Wujec, Arkadiusz Gzil, Daria Piątkowska, Joanna Ligmanowska, Dariusz Grzanka
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:The Journal of Pathology: Clinical Research
Subjects:
EMT
epithelial–mesenchymal transition
MIF
macrophage migration inhibitory factor
ccRCC
clear cell renal cell carcinoma
Online Access:https://doi.org/10.1002/2056-4538.12365

Internet

https://doi.org/10.1002/2056-4538.12365

Similar Items